<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                         0001048477
<NAME>                        BioMarin Pharmaceutical Inc.
<MULTIPLIER>                  1,000
<CURRENCY>                    US Dollars

<S>                             <C>
<PERIOD-TYPE>                   3-Mos
<FISCAL-YEAR-END>               DEC-31-2000
<PERIOD-START>                  JUL-01-2000
<PERIOD-END>                    SEP-30-2000
<EXCHANGE-RATE>                 1
<CASH>                          16,098
<SECURITIES>                    31,407
<RECEIVABLES>                   3,030
<ALLOWANCES>                    (70)
<INVENTORY>                     446
<CURRENT-ASSETS>                51,414
<PP&E>                          26,993
<DEPRECIATION>                  (6,962)
<TOTAL-ASSETS>                  83,557
<CURRENT-LIABILITIES>           3,609
<BONDS>                         0
           0
                     0
<COMMON>                        37
<OTHER-SE>                      79,615
<TOTAL-LIABILITY-AND-EQUITY>    83,324
<SALES>                         671
<TOTAL-REVENUES>                3,498
<CGS>                           194
<TOTAL-COSTS>                   194
<OTHER-EXPENSES>                11,450
<LOSS-PROVISION>                0
<INTEREST-EXPENSE>              2
<INCOME-PRETAX>                 (8,148)
<INCOME-TAX>                    (8,148)
<INCOME-CONTINUING>             (8,148)
<DISCONTINUED>                  0
<EXTRAORDINARY>                 0
<CHANGES>                       0
<NET-INCOME>                    (8,148)
<EPS-BASIC>                     (0.23)
<EPS-DILUTED>                   (0.23)



</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission